MediWound Announces Positive Top-Line Results from Its Pivotal Phase 3 Study of NexoBrid® for Eschar Removal in Severe Thermal Burns – CBI
Homepage /  Press Release /  MediWound Announces Positive Top-Line Results from Its Pivotal Phase 3 Study of NexoBrid® for Eschar Removal in Severe Thermal Burns

Press Release

MediWound Announces Positive Top-Line Results from Its Pivotal Phase 3 Study of NexoBrid® for Eschar Removal in Severe Thermal Burns